Is There a Tendency for Thrombosis in Gestational Diabetes Mellitus?
Is There a Tendency for Thrombosis in Gestational Diabetes Mellitus?
复制标题
DOI:
10.4103/0974-2727.180790
复制
发表时间:
2016-07
影响因子:
1.1
通讯作者:
Aral Y
中科院分区:
文献类型:
--
作者:
Gorar S;Alioglu B;Ademoglu E;Uyar S;Bekdemir H;Candan Z;Saglam B;Koc G;Culha C;Aral Y
Impact of gestational diabetes mellitus (GDM) on the coagulation system, dynamics involved at a pathophysiological level and the exact mechanism remain unclear. To evaluate the association between diabetes-related parameters and hemostatic factors to search for a tendency of thrombosis in GDM. Nineteen pregnant women who had GDM, 16 healthy pregnant and 13 healthy nonpregnant controls admitted to the Endocrinology outpatient clinics were enrolled in the study. Fasting and postprandial glucose, hemoglobin A1c and insulin levels, and insulin resistance; fructosamine, thrombin activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor Type-1 (PAI-1), tissue-type plasminogen activator (t-PA), fibrinogen, plasminogen and hemoglobin levels, platelet counts, prothrombin time (PT), and activated partial thromboplastin time (aPTT) were studied. One-way analysis of variance, Kruskal–Wallis, and post hoc Tukey honestly significant difference or Conover's nonparametric multiple comparison tests for comparison of the study groups. PT and aPTT were significantly lower in GDM patients compared to controls (P < 0.05), whereas fibrinogen and plasminogen levels were significantly higher in this group compared to both nonpregnant and healthy pregnant controls (P < 0.05 for each). TAFI, TFPI, PAI-1, and tissue t-PA levels were not significantly different among groups. Our findings indicate tendency to develop thrombosis in GDM similar to diabetes mellitus; but more comprehensive studies with larger sample size are needed to determine the relationship between GDM and hemostasis.